Back to search

Peptide record

TPDB25199

Antibacterial Anticancer Toxicity standard
14 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB25199
Antibacterial Anticancer Toxicity
Anti-infective peptides Cancer-related peptides Toxicity and safety peptides
Peptipedia CancerPPD 2.0
standard
No
A 14-aa standard natural multi-activity (Antibacterial, Anticancer, and Toxicity) peptide sequence curated from Peptipedia and CancerPPD 2.0, with an available 3D structural model.
Sequence
RRWFWRRRRWFWRR
Physicochemical Analysis
C110H156N42O15
ANDCEQGHILKMPSTYV
R
2306.72
13.25
8
0
6
+8
-3.18
-2.429
0.00
Mammalian: 1 hour Yeast: 2 min E.coli: 2 min
22000
953.73
0
Residue Composition
number
0
A
8
R
0
N
0
D
0
C
0
E
0
Q
0
G
0
H
0
I
0
L
0
K
0
M
2
F
0
P
0
S
0
T
4
W
0
Y
0
V
Amino Acid Distribution
A: 0 R: 8 N: 0 D: 0 C: 0 E: 0 Q: 0 G: 0 H: 0 I: 0 L: 0 K: 0 M: 0 F: 2 P: 0 S: 0 T: 0 W: 4 Y: 0 V: 0
Chemical Descriptors
14
C110H156N42O15
2306.72
13.25
+8
-3.18
-2.429
Evidence Records 3 records
Evidence 1 Activity

Activity

LC50
Toxicity
107±2.7 µM
Cytotoxic
LC50 | 107±2.7 | µM | target cell: Human dermal fibroblasts

Target

Human dermal fibroblasts

Source & Reference

NA
DBAASP
Design of human lactoferricin derived antitumor peptides-activity and specificity against malignant melanoma in 2D and 3D model studies. | Biochim Biophys Acta | 2020
Evidence 2 Activity

Activity

LC50
Toxicity
113±2.5 µM
Cytotoxic
LC50 | 113±2.5 | µM | target cell: Human epidermal melanocytes

Target

Human epidermal melanocytes

Source & Reference

NA
DBAASP
Design of human lactoferricin derived antitumor peptides-activity and specificity against malignant melanoma in 2D and 3D model studies. | Biochim Biophys Acta | 2020
Evidence 3 Activity

Activity

Toxicity
Hemolytic Cytotoxic
Hemolytic_activity: Not available | Cytotoxicity: Not available

Target

erythrocytes

Source & Reference

NA
DRAMP
Biochim Biophys Acta Biomembr. 2020 Aug 1 1862(8):183268.